Relatlimab, an Immune Checkpoint Inhibitor that Blocks LAG-3, the Latest Drug to be Added to the Arsenal of Systemic Therapies for Melanoma: What Does a Surgical Oncologist Need to Know?

van Akkooi ACJ. Annals of Surgical Oncology, (Oct 16 2023), doi:10.1245/s10434-023-14416-0.

No abstract available